Addiction Treatment Forum reports on substance abuse news of interest to opioid treatment programs and patients in methadone maintenance treatment.
Data from a phase IV hepatic safety study show no evidence of liver toxicity from buprenorphine/naloxone and methadone.
“Doctors can tell their patients that neither buprenorphine/naloxone or methadone have apparent liver toxicity and can prescribe either medication without major concern for liver injury,” Dr. Andrew Saxon said.
http://www.medscape.com/viewarticle/776221
Source: Medscape.com – December 14, 2012
AT Forum is pleased to provide this opportunity to share information, experiences and observations about what's in the news. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. While we encourage comments that challenge or offer constructed criticism, we reserve the right to edit or remove any post, for any reason.
Thank you for taking the time to offer your thoughts.
© 2013 AT Forum Privacy/Terms of Use | Contact Us
By PDGACO payday loan